GLP-1 drugs linked to lower heart attack, heart failure and death risk in people with serious mental illness
A Journal of the American Heart Association study of health records from more than 218,000 adults with serious mental illness, type 2 diabetes and obesity found that those taking GLP-1 drugs had lower one- and three-year risks of heart attack, heart failure and death. The links were strongest for semaglutide and tirzepatide, and the authors say trials are now needed.
Image credit: WashU Brown School
Source: WashU Brown School (27 Oct 2026). Image: WashU Brown School.